Treatments:Diabetes

From Proteopedia
Jump to navigationJump to search

Contents

  • 1 Insulin
  • 2 Dipeptidyl peptidase IV Inhibitor
  • 3 Peroxisome Proliferator-Activated Receptor Agonist
  • 4 Glucagon-like peptide-1 (GLP-1) agonist
  • 5 Mechanism is not completely understood
  • 6 Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)
Insulin
  • Lantus - Generic: Insulin glargine
  • NovoLog - Generic: Insulin aspart
  • Humalog - Generic: Insulin lispro
Dipeptidyl peptidase IV Inhibitor
  • Galvus - Generic: Vildagliptin
  • Januvia - Generic: Sitagliptin; see also Januvia (sitagliptin)
  • Onglyza - Generic: Saxagliptin
Peroxisome Proliferator-Activated Receptor Agonist
  • Actos - Generic: Pioglitazone
  • Avandia - Generic: Rosiglitazone
Glucagon-like peptide-1 (GLP-1) agonist
  • Victoza - Generic: Liraglutide
  • Ozempic - Generic: Semaglutide
Mechanism is not completely understood
  • Metformin - Generic: N,N-dimethylbiguanide
Inhibitors of the sodium glucose co-transporter-2 (SGLT-2)
  • Empagliflozin - Generic: Jardiance
  • Canagliflozin
  • Dapagliflozin

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, David Canner, Michal Harel, Karsten Theis

proteopedia link
Retrieved from "https://proteopedia.org/index.php?title=Treatments:Diabetes&oldid=4293355"

Navigation menu

Page actions

  • Page
  • Discussion
  • Read
  • View source
  • History

Page actions

  • Page
  • Discussion
  • More
  • Tools

Personal tools

  • Log in
  • Request account

Navigation

  • Main Page
  • Table of Contents
  • Structure Index
  • Random
  • Recent Changes
  • Help
  • Cookbook

Tools

  • What links here
  • Related changes
  • Special pages
  • Printable version
  • Permanent link
  • Page information
Powered by MediaWiki
  • Proteopedia is hosted by the ISPC at the Weizmann Institute of Science in Israel


    This page was last modified 07:43, 8 January 2025.

  • Privacy policy
  • About Proteopedia
  • Disclaimers
  • Mobile view